Categories

Above the Fold

PHARMA: The New York Times opinion on GSK and Spitzer

I’ve refrained from getting too much into the Spitzer versus Glaxo legal shenanigans over Paxil, and whether results were withheld deliberately or not. However, suffice it to say that yet again Pharma’s PR is not exactly going to be helping the Republicans in an election year when you see editorial pieces like this from The New York Times.

TECHNOLOGY: Biomimetics

Robert Mittman has another iHealthbeat article out in his technology Foresight Series. This one is on the connection between nature and human technology, known as Biomimitecs. Well worth a read.

POLICY/HEALTH PLANS: What’s the end game of all these premium rises?

I spent the last couple of days at an IFTF conference which looked at impediments to improving health and creating a better health care system–a small topic as you may have guessed. I’ll report a little more about the conference in due course but one of the most interesting talks was from Brad Kimler from Fidelity Investments, who laid out then projected future costs of health care, and the consequent impact on what a couple retiring at 65 would need to have saved to pay their premiums for Medicare and cover their out of pocket expenses. The number was $175,000! And if you are 45 now, you’ll need $650,000 by the time you’re 65. And neither of these included long term care. In fact for a retired couple with a good pension plan, and retiree insurance from their company, by 2015 80% of their income will be going to pay their health care premiums. There was a certain amount of shock and awe around the room. While Brad admitted some self-serving interest in getting people to save more (and have Fidelity manage that process), we still have an enormous challenge facing us as a society. Currently the average 401K account retiree at Fidelity has under $100,000 in it, and of course there are no real funds in dedicated health care retirement accounts yet.

What’s even more intriguing is that Brad based his calculations on an 8% increase in costs. Of course recently we’ve seen even bigger increases in costs. Hewitt Associates yesterday came out suggesting that employers will face premium increases of up to 14%. Unless we generate some amazing productivity miracle and get much richer very quickly, there are only two ways that this can go, as the baby boomers start moving into their 60s (starting next year). Either we start dropping more people into un- or underinsurance, or we add more people to something like the Medicare program. That of course that eventually means either higher taxes for working people or lower incomes for the people providing health care services and products.

From the THCB Sacramento office Matt Quinn, who wasn’t at the conference, seems to be thinking in similar ways:

    Hewitt Associates estimates that health insurers will seek 14% premium hikes from employer groups, but probably won’t get all of it. The survey notes that all of the major insurers surveyed seem to be "pricing rationally": they are reflecting increases in medical costs as increases in premiums. And – at least before they get into negotiations with large employers – none of them seems to be playing the "take a loss / make it up on volume" ponzi scheme of the past. What the survey doesn’t note, however, is how much of these premium increases employers will pass onto their employees (or how many employers will simply drop coverage for some or all employees).

    So that leaves us with the current state of affairs: Employers (purchasers) expect to pay double digit premium increases each year, but can only "afford" single digit increases. Health insurers expect that their medical costs will increase at a double digit clip each year – and faster when the baby boomers hit. Hospital and drug costs are rapidly increasing, while almost all physicians expect – and most non-primary care physicians are receiving – annual pay raises. And consumers continue to want the "best" (i.e. newest and most heavily advertised) care at low or no cost.

    The recent CalPERS showdown with Sutter (and other "expensive" hospitals) illustrates the growingly activist role of purchasers in managing costs, but their efforts are clearly not stemming the tide. And, as we have seen at GE, SBC, and Safeway, employee tolerance for healthcare cost increases is quite low.

    I think that only one question remains: Who – other than the federal government – has the market clout to manage the cost and quality of care?

Several of the representatives from large employers at the meeting yesterday were starting to mouth the same opinion. Don’t expect anything big to happen with this Administration or Congress, so realistically even with a Kerry presidency this won’t be on the front burner till 2008-12. But absent a 1990s type productivity boom, this question is not going away.

TECHNOLOGY: Has the time come for low-cost, standardized EMRs? by Matt Quinn

Not long ago, I postulated about the idea of giving Don Berwick the $100M the federal government has set aside for healthcare IT to develop an open source enterprise EMR system.

It seems that CMS is going down that road with this $100,000 grant to the AAFP… although I can’t imagine that $100K will get them far at all (perhaps a requirements document?). Ideally, a project like this should be a public /private partnership: the government has money, trade organizations (are supposed to) understand the needs of healthcare workers (the "voice of the customer") and healthcare IT vendors / consulting firms (are supposed to) know how to develop and deploy scalable, reliable software/web-based applications.

TECHNOLOGY: WebMD probs continue

I’ve blogged over time about WedMD’s role as a business (three variant parts plus a plastics company looking in vain for synergies) and it’s role as a potential analytics player. However, in its role as a claims transaction clearinghouse and processor (the former Envoy-NEIC), WebMD does not appear to be out of the woods from complaints about its inability to route and process claims.

Given that we are nine years on from Jim Clark’s vision of a transaction system in the middle of health care routing all that paper to the right place in the blink of an eye, the fact that the most hyped health care IT company of all time cannot get its systems to work is a little disappointing. Even the pessimists among us meeting Healtheon for the first time in 1995 might have hoped for a little better by now!

PHARMA: Overdosing on ED

In case you were worried that Pfizer was losing some lead from its pencil–and there have been some rumors about new scripts for Levitra and Cialis doing pretty well– MedAdNews reports that apparently Viagra is staring down its rivals. Of course, there is some controversy, as has been replayed (to excess) over at the Pharma Marketing News list serv, that the number of men with ED in the US seems to be expanding to meet the number of men over 16 (100m was one number quoted!) but it does seem as though this "lifestyle" drug will remain a cash cow for Pfizer until it comes off patent.

PHARMA: The progress of reimportation, by The Industry Veteran

It looks like the Senate is going to pass the re-importation bill and then try to force the House to come on board. If, as I’ve been saying for a while, the Republicans are going to cave on this and do something before the election to preserve what little credibility the Medicare PDIMA bill has left with seniors, it’s worth thinking through what might happen next. Luckily for me and you, The Industry Veteran has already done so, so strap yourself in for a typically meek analysis of what’s going on. (Note that this piece is a couple of weeks old, as it was lost in my inbox mess on my vacation, but it holds truer today than when it was written!)

    Republicans in Congress have finally acceded to the public’s demand for ready access to pharmaceuticals reimported from Canada and other countries. HHS Secretary Thompson said he will advise George Bush not to oppose the effort. This means the President must focus his pharisaical, malevolent gaze at Hank McKinnell, Fred Hassan and the other plutocrats of Big Pharma and tell them that despite their $100 million contributions to his cloak-fascism-with-Christ administration, he has to look out for himself. In the short run this will provoke wounded howls and threats about the loss of high paying jobs, but Big Pharma is apt to remain one of the world’s most profitable industries. Organized medicine, for example, resisted Medicare from the 1940s through the mid-60s with shrieks about socialized medicine. As a result of LBJ finally getting the legislation through, physicians annual incomes rose from $50,000, respectable at the time, to the point where today, oncologists earn a median income of $450,000 and leave respectability behind them in the dust.

    The Republicans intent to actually permit some form of reimportation appears from the fact that their proposal was drafted by the Chairman of the Senate s Health, Education and Labor Committee, Judd Gregg, at the behest of the Senate Majority Leader, HCA’s Bill Frist. The legislation would permit transhipment from other countries, through Canada, providing: (1) the FDA can approve facilities through which the drugs pass and; (2) the tracking (or "pedigree") of shipments can be maintained.

    Some features in Gregg’s bill include:

    — Individuals can receive their prescription medications (a maximum 90-day supply at a time) from licensed pharmacies in Canada or up to 15 EU countries approved by the FDA. All businesses involved in reimportation must register with the FDA, submit to FDA inspections and must permit the agency to detain or suspend shipments in theinterests of public safety;

    –Internet pharmacies must comply with all current, federal, state and local regulations governing pharmacy practice;

    –Importers must identify entry ports, provide advance notice of incoming shipments, and grant the FDA authority to mark suspected shipments in order to prevent their entry into another port;

    The details in which Republican devils (a tautology if there ever was one) may lurk involve the requirement that pharmacies, wholesalers and others in the distribution channel must maintain a pedigree of a shipment’s s immediately prior source and subsequent recipient. Shipments from Canada would need to identify all previous entities in the supply chain. The import system would establish a user fee for all participating businesses, the money presumably enabling the FDA to discharge these oversight responsibilities.In principle the facility approval and tracking provisions appear desirable as measures for controlling the drug counterfeiting that occurs even today in the U.S.’ loosely monitored landscape of mom-and-pop wholesalers. It remains an open question, however, whether a Bush-influenced FDA that orders its top reviewer not to comment about a drugs hazards at an advisory committee hearing can capriciously seize upon ambiguous situations to logjam the entire process.

UPDATE: Gregg was reported to be introducing the bill by the Washington Post this morning

POLICY: The war on pain doctors

Like Robert Centor at MedRants, Chris Rangel MD and many, many others I’m a strong opponent of the War on Drugs, but I rarely bring that up in THCB. That’s because the Drug War is largely a political, social and criminal justice issue rather than a health care issue. However, in one arena, the War on Drugs–as prosecuted both by Ashcroft’s justice department and many Republican and Democrat state and local attorneys-general is not only completely out of control, but is a direct assault on health care provision.

I’m referring of course to the draconian prosecutions of physicians who treat chronic pain by prescribing opiates. Given my other recent posts on access to rural healthcare in California, the case of Dr. Frank Fisher is very relevant. Fisher is a Harvard trained doc, who until 1999 was running a general health center for the poorer residents of Shasta county–a very rural area in far northern California–including pain management. Some time around 1996 the California and Federal authorities decided to come after him because a few people had died with only the vaguest connections to his prescribing of opiates. One had been in a car crash where he was the passenger. The charges faced by Fisher? Murder!

Last week, five years later, Fisher was cleared at trial of the only remaining criminal charge. That charge was of defrauding Medi-Cal of, wait for it, $150! (I know THCB has been critical of non-prosecution of fraud in the Medi-Cal system, but that wasn’t what we meant!). So now Fisher has to get the state medical board to give him his license back in order to go back to work. Given the history of outright lying and corrupt behavior by prosecutors in this case, that ought to be simple. Whether any of those individuals will be held accountable is less likely.

Meanwhile, what do you think happened to the patients at his clinic, which was destroyed by this action? Go read the full interview with Fisher at DRCNet, but this is an extract about what happened to the people he was serving. As you might have guessed their transition from his care to that of others in that rural underserved area was not exactly smooth:

    You ran a large clinic serving a predominantly poor and rural clientele. What happened to your patients after your practice was shut down?

    Fisher: The impact on the patients has been devastating, it’s been an unmitigated disaster. Their health has deteriorated, they’ve been unable to get medical care, some appear to have aged 20 years in five years, others haven’t even survived. Some patients have gained enormous amounts of weight, others have their blood pressure out of control. I suspect there has been at least one suicide. Patients are having to travel great distances to get their care; they go to Eugene or Fresno or San Francisco. Of the patients I still talk to, I don’t think a single one is being adequately treated.

    Chronicle: The majority of your patients were Medi-Cal patients, poor people. Is there a class issue involved in the availability of pain treatment?

    Fisher: The availability of pain management for poor people is even worse than for the rest of us. And it’s not good for the rest of us. Everyone who develops chronic pain is likely to be killed by it because of medical neglect. It’s a malignancy in the sense that if it is not controlled, it will spread and progress. My patients were effectively tossed out on the street to fend for themselves. The local medical clinic saw them as drug addicts who needed to be detoxed.

POLICY: A rural California MD comments on the CHCF studies

Leonard Soloniuk, MD, wrote in to THCB to comment on my post on Frday linking the care for Medicaid and uninsured patients in California with the Canadian experience. A post in which I was a little shrill about certain American and Canadian critics of the Canadian system. He has an interesting perspective on the type of problems the CHCF reports were describing.

    I’m always surprised by the continued criticism that the Canadian health care system gets for lack of access when I see equally serious problems in the US.

    My perspective: I am a specialist in a rural, mostly indigent county in Far Northern California. Medi-Cal patients can get primary care easily enough (wait list for a new patient is about 2 months) because the county clinic is heavily subsidized by the Feds and the state (the clinic gets about $75 per patient visit, while I get about $18 per Medi-Cal patient visit). Because of the disconnect between cognitive and procedural reimbursement (a whole different subject), there is usually not much of a problem getting surgery for Medi-Cal patients. Medi-Cal actually pays better than private insurance for many surgeries. However, there are still significant waits for certain specialities: 12 months for Urology, 6-12 months for Neurosurgery, for example. For non-procedural specialities, there are significant delays, such as 12 months for Rheumatology.

    These waits sound just as bad as the Canadian system, but I just don’t see them mentioned in articles comparing the two systems.

    Of course, the uninsured can face significant barriers to care. The barriers are so discouraging that it is my office policy not to see uninsured patients (I policy that I violate only once a week or so). I don’t see them because I can’t provide good care for them. I can’t order lab work, xrays, scans. Interestingly, the lowest barrier for the uninsured patient is for medications. Between samples and pharmaceutical programs for indigents, I can almost always get meds for the patients.

    Thinking about this issue some more, I think that the speciality with the worst problems for access to care is psychiatry. Access to mental health care is difficult even for insured patients, because of higher co-pays, etc. For the indigent, the resources are awful. “It really sucks to be mentally ill and poor in America.”

    I’ve never seen any comparison about access to mental health care in Canada or England. Any comments?

MEMORIAL DAY OFF

I’ll be taking Memorial Day off. If you are in DC for the holiday I highly reccomend the exhibit of WWII photos in Union station, where I passed a very pleasant hour wating for a train. Best wishes to all veterans of all wars (on all sides). Given that I just visited Turkey, I thought these words of Turkish leader Ataturk (who led the Turkish army at Gallipoli), written to a group of Australian parents visiting Gallipoli in 1934, are very appropriate:

    Those heroes that shed their blood and lost their lives; You are now lying in the soil of a friendly country.Therefore rest in peace. There is no difference between the Johnnies and the Mehmets to us where they lie side by side here in this country of ours. You, the mothers, who sent their sons from far away countries, wipe away your tears;your sons are now lying in our bosom and are in peace. After having lost their lives on this land they have become our sons as well.